soul trial oral semaglutide cardiovascular outcomes 2024 results nejm and in... : New England Journal of Medicine Cardiovascular Outcomes Associated with Semaglutide
Description
doi: 10.2147/DDDT.S46970
[DOI] [PubMed] [Google Scholar] 43.Lauder L., Mahfoud F., Azizi M., Bhatt D.L., Ewen S., Kario K., Parati G., Rossignol P., Schlaich M.P., Teo K.K., et al
The efficacy of liraglutide 3.0 mg was evaluated in T2DM patients with a body mass index (BMI) 27 kg/m 2 treated with diet and exercise alone or in combination with antidiabetic drugs
Consider reporting the incident to FDA MedWatch if adverse effects occur
A: To maintain potency and shelf life, always store the tablets below 30C and keep them away from moisture, as recommended in the product's storage instructions
